Okamoto Y, Satomura K, Ohsuzu F, Nakamura H, Takeuchi K, Yoshioka M
First Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
J Atheroscler Thromb. 2001;8(2):50-4. doi: 10.5551/jat1994.8.50.
In atherosclerotic lesions, matrix metalloproteinases produced by foam cells (macrophages) are thought to increase plaque instability, promote plaque rupture, by degradating extracellular matrix. To investigate the relationship between the expression of these proteinases and the histologic appearance of atheromas, immunohistochemical analysis of matrix metalloproteinase 3 and cell-type markers was performed in atherosclerotic plaques induced in rabbit abdominal aortas by high-cholesterol diets and mechanical injury. In addition to an antibody against matrix metalloproteinase 3, RAM-11 and HHF-35 were used to detect macrophages and smooth muscle cells, respectively. Matrix metalloproteinase 3 was expressed diffusely within the plaques with a fibrofatty histologic pattern. In plaques with foam cell accumulation, matrix metalloproteinase 3 was seen in areas rich in foam cells and the smooth muscle cells near the lumen. In the plaques with fewer macrophages, the proteinase was expressed only in such smooth muscle cells. Matrix metalloproteinase 3 was expressed in the smooth muscle cells in plaques of all histologic types, and macrophages also expressed the metalloproteinase when present in significant numbers. These findings suggest that macrophage accumulation plays an important pathophysiologic role in causing the instability of atherosclerotic lesions by increasing the levels of matrix metalloproteinase 3.
在动脉粥样硬化病变中,泡沫细胞(巨噬细胞)产生的基质金属蛋白酶被认为会通过降解细胞外基质增加斑块不稳定性,促进斑块破裂。为了研究这些蛋白酶的表达与动脉粥样瘤组织学表现之间的关系,对高胆固醇饮食和机械损伤诱导的兔腹主动脉粥样硬化斑块进行了基质金属蛋白酶3和细胞类型标志物的免疫组织化学分析。除了抗基质金属蛋白酶3抗体外,还分别使用RAM-11和HHF-35检测巨噬细胞和平滑肌细胞。基质金属蛋白酶3在具有纤维脂肪组织学模式的斑块内弥漫性表达。在有泡沫细胞积聚的斑块中,在富含泡沫细胞的区域和靠近管腔的平滑肌细胞中可见基质金属蛋白酶3。在巨噬细胞较少的斑块中,该蛋白酶仅在平滑肌细胞中表达。基质金属蛋白酶3在所有组织学类型的斑块中的平滑肌细胞中均有表达,并且当巨噬细胞数量较多时也表达该金属蛋白酶。这些发现表明,巨噬细胞积聚通过增加基质金属蛋白酶3的水平,在导致动脉粥样硬化病变不稳定方面发挥重要的病理生理作用。